Correlation Between Europlasma and Gensight Biologics

Can any of the company-specific risk be diversified away by investing in both Europlasma and Gensight Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Europlasma and Gensight Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Europlasma SA and Gensight Biologics SA, you can compare the effects of market volatilities on Europlasma and Gensight Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Europlasma with a short position of Gensight Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Europlasma and Gensight Biologics.

Diversification Opportunities for Europlasma and Gensight Biologics

0.75

Correlation Coefficient

Europlasma  Gensight Biologics

Poor diversification

The 3 months correlation between Europlasma and Gensight is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Europlasma SA and Gensight Biologics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gensight Biologics and Europlasma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Europlasma SA are associated (or correlated) with Gensight Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gensight Biologics has no effect on the direction of Europlasma i.e., Europlasma and Gensight Biologics go up and down completely randomly.

Pair Corralation between Europlasma and Gensight Biologics

Assuming the 90 days trading horizon Europlasma SA is expected to generate 4.17 times more return on investment than Gensight Biologics. However, Europlasma is 4.17 times more volatile than Gensight Biologics SA. It trades about 0.01 of its potential returns per unit of risk. Gensight Biologics SA is currently generating about 0.0 per unit of risk. If you would invest  17.00  in Europlasma SA on September 4, 2024 and sell it today you would lose (9.35) from holding Europlasma SA or give up 55.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Europlasma SA  vs.  Gensight Biologics SA

Europlasma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Europlasma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively weak basic indicators, Europlasma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Gensight Biologics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Gensight Biologics SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Gensight Biologics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Europlasma and Gensight Biologics

The main advantage of trading using opposite Europlasma and Gensight Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Europlasma position performs unexpectedly, Gensight Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gensight Biologics will offset losses from the drop in Gensight Biologics' long position.

The idea behind Europlasma SA and Gensight Biologics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.